Robert Ezzell

Corporate Officer/Principal at ATAI LIFE SCIENCES N.V.

Health Technology

Consumer Services

Health Services

Profile

Robert Ezzell is currently a Senior Director-Regulatory Affairs at ATAI Life Sciences NV since 2021.
Prior to this, he worked as a Director-Product Development at RenaMed Biologics, Inc., a Director-Regulatory Affairs at Glympse Bio, Inc., and an Assistant Professor at Harvard Medical School.
He holds a doctorate degree from the University of California, Berkeley.

Robert Ezzell active positions

Companies	Position	Start
ATAI LIFE SCIENCES N.V.	Corporate Officer/Principal	2020-12-31

All active positions of Robert Ezzell

Former positions of Robert Ezzell

Companies	Position	End
RenaMed Biologics, Inc. RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI.	Corporate Officer/Principal	-
Harvard Medical School	Corporate Officer/Principal	-
Glympse Bio, Inc. Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.	General Counsel	-

See the detail of Robert Ezzell's experience

Training of Robert Ezzell

University of California, Berkeley

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Ezzell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ATAI LIFE SCIENCES N.V.	Health Technology

Private companies	2
Glympse Bio, Inc. Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.	Health Technology
RenaMed Biologics, Inc. RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI.	Health Services